FDA
approval
· 2020-02-21
FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for Buspirone Hydrochloride by Aurobindo Pharma Limited, authorizing continued manufacture and supply under the ANDA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)